Aqr Capital Management LLC Neogenomics Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $119,763 - $143,017	-8,518 Reduced 41.72%	11,901 $187,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $93 - $165	8 Added 0.04%	20,419 $330,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $55,063 - $80,896	4,532 Added 28.54%	20,411 $251,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $223,893 - $314,880	15,879 New	15,879 $255,000
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $136,398 - $255,244	-21,147 Reduced 57.66%	15,529 $143,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $137,832 - $226,389	17,536 Added 91.62%	36,676 $316,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $49,716 - $98,376	7,042 Added 58.21%	19,140 $156,000
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $18,978 - $55,107	-1,562 Reduced 11.43%	12,098 $147,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $46,253 - $73,559	-1,517 Reduced 10.0%	13,660 $466,000
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $1.13 Million - $1.63 Million	-27,274 Reduced 64.25%	15,177 $732,000
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $1.17 Million - $1.83 Million	-32,395 Reduced 43.28%	42,451 $2.29 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $1.12 Million - $1.36 Million	-33,594 Reduced 30.98%	74,846 $2.76 Million
Q2 2020 Aug 17, 2020	SELL	$24.21 - $31.02 $778,375 - $997,324	-32,151 Reduced 22.87%	108,440 $3.36 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $948,535 - $1.6 Million	46,270 Added 49.06%	140,591 $3.88 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $1.27 Million - $2 Million	-66,971 Reduced 41.52%	94,321 $2.76 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $1.21 Million - $1.67 Million	-63,487 Reduced 28.24%	161,292 $3.08 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $1.39 Million - $1.71 Million	70,829 Added 46.01%	224,779 $4.93 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $98,443 - $165,910	-8,109 Reduced 5.0%	153,950 $3.15 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $1.51 Million - $2.49 Million	134,418 Added 486.3%	162,059 $2.04 Million
Q3 2018 Nov 15, 2018	BUY	$12.5 - $15.38 $186,862 - $229,915	14,949 Added 117.78%	27,641 $424,000
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $73,284 - $128,866	-9,172 Reduced 41.95%	12,692 $166,000
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $199,181 - $246,188	21,864	21,864 $243,000

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$285 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$204 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$99.9 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$95.7 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$94.9 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account